Literature DB >> 32869209

New Proluciferin Substrates for Human CYP4 Family Enzymes.

Jingyao Liu1, David Machalz2, Gerhard Wolber2, Erik J Sorensen3,4, Matthias Bureik5.   

Abstract

We report the synthesis of seven new proluciferins for convenient activity determination of enzymes belonging to the cytochrome P450 (CYP) 4 family. Biotransformation of these probe substrates was monitored using each of the twelve human CYP4 family members, and eight were found to act at least on one of them. For all substrates, activity of CYP4Z1 was always highest, while that of CYP4F8 was always second highest. Site of metabolism (SOM) predictions involving SMARTCyp and docking experiments helped to rationalize the observed activity trends linked to substrate accessibility and reactivity. We further report the first homology model of CYP4F8 including suggested substrate recognition residues in a catalytically competent conformation accessed by replica exchange solute tempering (REST) simulations.

Entities:  

Keywords:  CYP4Z1; Cytochrome P450; Docking; Fission yeast; Homo sapiens; Pharmacology; Proluciferin; Site of metabolism prediction

Mesh:

Substances:

Year:  2020        PMID: 32869209     DOI: 10.1007/s12010-020-03388-6

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  34 in total

1.  Efficient substrate screening and inhibitor testing of human CYP4Z1 using permeabilized recombinant fission yeast.

Authors:  Qi Yan; David Machalz; Andy Zöllner; Erik J Sorensen; Gerhard Wolber; Matthias Bureik
Journal:  Biochem Pharmacol       Date:  2017-09-23       Impact factor: 5.858

Review 2.  Gene-directed enzyme prodrug therapy.

Authors:  Jin Zhang; Vijay Kale; Mingnan Chen
Journal:  AAPS J       Date:  2014-10-23       Impact factor: 4.009

Review 3.  Contribution of cytochrome P450 to the diversification of eukaryotic organisms.

Authors:  Tsuneo Omura
Journal:  Biotechnol Appl Biochem       Date:  2013 Jan-Feb       Impact factor: 2.431

4.  Functional expression and activity screening of all human cytochrome P450 enzymes in fission yeast.

Authors:  Pradeepraj Durairaj; Linbing Fan; Wei Du; Shabir Ahmad; Dawit Mebrahtu; Shishir Sharma; Rana Azeem Ashraf; Jiaxin Liu; Qian Liu; Matthias Bureik
Journal:  FEBS Lett       Date:  2019-05-30       Impact factor: 4.124

Review 5.  Human cytochromes P450 in health and disease.

Authors:  Daniel W Nebert; Kjell Wikvall; Walter L Miller
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-06       Impact factor: 6.237

6.  Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers.

Authors:  Diane Downie; Morag C E McFadyen; Patrick H Rooney; Margaret E Cruickshank; David E Parkin; Iain D Miller; Colin Telfer; William T Melvin; Graeme I Murray
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

7.  Plasma membrane localization of CYP4Z1 and CYP19A1 and the detection of anti-CYP19A1 autoantibodies in humans.

Authors:  Christopher Khayeka-Wandabwa; Xiaoshuang Ma; Xiaolin Cao; Venkatrao Nunna; Janak L Pathak; Rita Bernhardt; Pengcheng Cai; Matthias Bureik
Journal:  Int Immunopharmacol       Date:  2019-05-10       Impact factor: 4.932

8.  Human CYP4Z1 catalyzes the in-chain hydroxylation of lauric acid and myristic acid.

Authors:  Andy Zöllner; Calin-Aurel Dragan; Dominik Pistorius; Rolf Müller; Helge B Bode; Frank T Peters; Hans H Maurer; Matthias Bureik
Journal:  Biol Chem       Date:  2009-04       Impact factor: 3.915

9.  Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma.

Authors:  Michael A Rieger; Reinhard Ebner; David R Bell; Andrea Kiessling; Jacques Rohayem; Marc Schmitz; Achim Temme; E Peter Rieber; Bernd Weigle
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

10.  Expression and Functional Characterization of Breast Cancer-Associated Cytochrome P450 4Z1 in Saccharomyces cerevisiae.

Authors:  Matthew G McDonald; Sutapa Ray; Clara J Amorosi; Katherine A Sitko; John P Kowalski; Lorela Paco; Abhinav Nath; Byron Gallis; Rheem A Totah; Maitreya J Dunham; Douglas M Fowler; Allan E Rettie
Journal:  Drug Metab Dispos       Date:  2017-10-10       Impact factor: 3.922

View more
  1 in total

1.  WGCNA combined with GSVA to explore biomarkers of refractory neocortical epilepsy.

Authors:  Rui Zhang; Yan Chen; Jia He; Hai-Yan Gou; Yu-Lan Zhu; Yan-Mei Zhu
Journal:  IBRO Neurosci Rep       Date:  2022-10-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.